An Open-Label, Randomized, Single-Dose, 2-Period Crossover Study to Determine the Effect of a High-Fat Meal on the Relative Bioavailability and Pharmacokinetics of a Single Dose of Bosutinib Administered Orally to Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 17 Mar 2010
At a glance
- Drugs Bosutinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Pharmacokinetics
- Sponsors Wyeth
- 17 Mar 2010 111th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics
- 05 Feb 2009 Additional location identified as reported by ClinicalTrials.gov, last updated 5-2-2009.
- 05 Feb 2009 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.